ProMIS™ Neurosciences
Biotechnology Research • 
Toronto, Ontario, Canada • 11-20 Employees
Company overview
| Headquarters | 1920 Yonge St., Suite 200, Toronto, Ontario M4S 3E2, CA |
| Phone number | +14168476898 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotechnology, Neurodegenerative Diseases, Neurosciences, Alzheimer'S Disease, Protein Folding, Amyotrophic Lateral Sclerosis (Als), Precision Molecular Targeting, Toxic Oligomers |
| Founded | 2015 |
| Employees | 11-20 |
| Socials |
Key Contacts at ProMIS™ Neurosciences
Eugene Williams
Chairman And Co-Founder
Misty Lamendola
Director, Clinical Operations
Beibei Zhao
Director, Research Programs
Heidi Urish Pavia
Associate Director, Clinical Operations
Max Milbury
Director, Finance
Carissa Biller
Executive Assistant To Chief Executive Officer
ProMIS™ Neurosciences Email Formats
ProMIS™ Neurosciences uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@promisneurosciences.com), used 71.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@promisneurosciences.com | 71.4% |
{first name}.{last name} | john.doe@promisneurosciences.com | 21.4% |
{first name} | john@promisneurosciences.com | 7.1% |
About ProMIS™ Neurosciences
ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases. The Company’s proprietary target discovery engine, EpiSelect™, predicts novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins that cause neurodegenerative and other misfolded protein diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), multiple system atrophy (MSA), and Parkinson’s Disease (PD). ProMIS has offices in Cambridge, Massachusetts (USA) and Toronto, Ontario (CAN).
ProMIS™ Neurosciences revenue & valuation
| Annual revenue | $364,500,000 |
| Revenue per employee | $18,221,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,166,200,000 |
| Total funding | $57,400,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
ProMIS™ Neurosciences has 9 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore ProMIS™ Neurosciences's funding history, including investment rounds, total capital raised, and key backers.
ProMIS™ Neurosciences Tech Stack
Discover the technologies and tools that power ProMIS™ Neurosciences's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
Tag managers
Hosting
Analytics
JavaScript libraries
Security
JavaScript libraries
Miscellaneous
Cookie compliance
Miscellaneous
UI frameworks
United Arab Emirates
United Kingdom
Netherlands
Frequently asked questions
4.8
40,000 users
